about
Chimpanzee malaria parasites related to Plasmodium ovale in AfricaAfrican apes as reservoirs of Plasmodium falciparum and the origin and diversification of the Laverania subgenusDifferent selective pressures shape the evolution of Toll-like receptors in human and African great ape populationsIncreased risk of Q151M and K65R mutations in patients failing stavudine-containing first-line antiretroviral therapy in CambodiaAfrican great apes are naturally infected with roseoloviruses closely related to human herpesvirus 7Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N.Plasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women.Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptomsHigh survival and treatment success sustained after two and three years of first-line ART for children in Cambodia.Synonymous mutations in the core gene are linked to unusual serological profile in hepatitis C virus infection.Genomic tools for evolution and conservation in the chimpanzee: Pan troglodytes ellioti is a genetically distinct populationPopulation pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates.Full-length genome sequence of a simian immunodeficiency virus (SIV) infecting a captive agile mangabey (Cercocebus agilis) is closely related to SIVrcm infecting wild red-capped mangabeys (Cercocebus torquatus) in Cameroon.Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in CambodiaHigh efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, CambodiaVery high concentrations of active intracellular phosphorylated emtricitabine in neonates (ANRS 12109 trial, step 2).Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial)Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii).Molecular characterization of a new mosaic Simian Immunodeficiency Virus in a naturally infected tantalus monkey (Chlorocebus tantalus) from Cameroon: a challenge to the virus-host co-evolution of SIVagm in African green monkeys.Prediction of treatment failure using 2010 World Health Organization Guidelines is associated with high misclassification rates and drug resistance among HIV-infected Cambodian childrenEarlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.Extensive drug resistance in HIV-infected Cambodian children who are undetected as failing first-line antiretroviral therapy by WHO 2010 guidelines.DC-SIGN from African green monkeys is expressed in lymph nodes and mediates infection in trans of simian immunodeficiency virus SIVagm.Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonatesIn-house HIV-1 RNA real-time RT-PCR assays: principle, available tests and usefulness in developing countries.Simian immunodeficiency virus infection in wild-caught chimpanzees from cameroon.Current challenges to viral load testing in the context of emerging genetic diversity of HIV-1.SIVcpz in wild chimpanzees.Mother-to-child transmission of human immunodeficiency virus type 1 in relation to the season in Yaounde, Cameroon.Adherence to PI-based 2nd line regimens in Cambodia is not simply a question of individual behaviour: the ANRS 12276 2PICAM study.Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses.Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.Vpu-mediated CD4 down-regulation and degradation is conserved among highly divergent SIV(cpz) strains.Zoonotic Transmission of Two New Strains of Human T-lymphotropic Virus Type 4 in Hunters Bitten by a Gorilla in Central Africa.Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test.Detection of cytomegalovirus DNA on dried blood spots collected from infants infected with HIV: an in-house method adaptable in resource-limited settings.Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance.Efficacy and safety of peginterferon alpha-2a/ribavirin in treatment-naive Cameroonian patients with chronic hepatitis C.Low risk of mother-to-child transmission of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study.
P50
Q21562422-E377A549-3C87-4043-9C91-676153194547Q24630492-F059BF72-CBA9-4027-83F0-A62CA6073654Q28294476-B0C88402-D280-4235-9D2D-6FA1E860C181Q28535850-C7AB6D53-E4B4-420E-9208-E4A385852D61Q28650835-C32637AE-132A-43E9-9FD8-68E0856F3C32Q30341867-91273734-78EF-4918-927C-E449678E9328Q30940547-16C939ED-B3B7-4B01-9237-30CF4A5C9E0AQ33393641-A03AFE59-F4A0-4448-90D4-5A6E61307565Q33776928-7C60363F-94A8-4BD8-BA64-86F3E8904E46Q33808516-546F2822-FF86-4E13-9568-E2F5E21E0E37Q34187012-AAC2188B-EE8A-4B21-8E59-44A314A8C7A0Q34483505-4D355F9D-11B2-41A7-82D1-A1CBDC2EC111Q34641769-BE475071-0B24-45A6-99EE-F2673C0F0DABQ34730386-000BB665-0BEC-48B7-A952-1E84EEEA4C44Q34769839-A698004C-95B6-403D-827D-5361B6920369Q35004837-C4B76147-8150-4A32-A8C7-3BE1853A4E04Q35114865-DDBF16B8-5360-484D-9411-7451F6197410Q35149459-3D02A65D-6DD1-4A08-9C82-6C4E7C14354AQ36376372-BAAC6D14-420E-40FE-915C-101C168C6904Q36379413-55AD9694-8E62-4198-9B46-FFB02B0367BFQ36934339-371EA88F-CD33-4910-B6B6-0711A3099E98Q36937877-778E61AE-433D-4C96-A74D-68CB1A29C17DQ36942836-F477F51A-2668-4AB1-88B9-81448C6270E5Q37115730-53474999-6B76-4249-A911-AF7D5CAC70FEQ37266495-CB7A6FE7-6E6E-4380-A3A2-68CEC3B4A199Q37743348-717E6CDE-EC80-419A-8AEB-803F72144CE4Q38088726-178DF829-6D58-4AAF-A99E-CB3E93198EE2Q38884711-2D579969-91DB-4757-A21A-B15394FFE413Q38885470-F5568DFE-6ABB-43E0-8AEC-C4CB3F39422FQ40041832-357B1993-93B6-4193-94B2-5AB7A7C9F4E4Q40069610-C0081411-8591-416E-BB23-E399ED3D2737Q40232525-33E9BAE5-2E02-4FAF-911D-D13E563B5A45Q40436581-DF3B6C35-2848-46A2-B403-0179449A2A55Q40690106-B1E37F91-1D7E-4CA3-B990-EF5861D4988BQ41449090-3BDB6DB2-2209-462B-8C65-E41A8FEE80DBQ42280986-623B5C23-2A07-48EF-A2EB-303180C9421AQ42630740-CEFCFC86-5148-463F-87BE-912A79E9D595Q42912913-5FC97494-09A1-4BEB-B27A-7D88C8DBEA7FQ42983433-5463F6BB-0EAE-4659-8F9B-7FB899B1FDF8Q42994440-8CD806CC-B7F4-4F77-90F7-1C64DE6D91DF
P50
name
Eric Nerrienet
@en
type
label
Eric Nerrienet
@en
prefLabel
Eric Nerrienet
@en